LS Investment Advisors LLC Makes New Investment in CVS Health Corporation $CVS

LS Investment Advisors LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 3,350 shares of the pharmacy operator's stock, valued at approximately $231,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 202 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of CVS Health in the first quarter worth about $34,000. Livelsberger Financial Advisory purchased a new position in CVS Health during the 2nd quarter valued at approximately $35,000. Finally, Costello Asset Management INC increased its stake in CVS Health by 281.3% in the 1st quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator's stock worth $39,000 after acquiring an additional 422 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

Insiders Place Their Bets

In other news, Director Anne A. Finucane sold 7,500 shares of the company's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Down 2.2%

NYSE:CVS opened at $74.71 on Friday. The company has a market cap of $94.75 billion, a price-to-earnings ratio of 20.87, a price-to-earnings-growth ratio of 0.84 and a beta of 0.62. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $77.34. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $68.85 and a 200-day simple moving average of $66.90.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health's revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. CVS Health's dividend payout ratio is presently 74.30%.

Analyst Ratings Changes

A number of research analysts recently weighed in on CVS shares. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Sanford C. Bernstein boosted their target price on shares of CVS Health from $72.00 to $77.00 and gave the stock a "market perform" rating in a report on Friday, September 5th. Robert W. Baird raised shares of CVS Health from a "neutral" rating to an "outperform" rating and increased their price target for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Zacks Research cut CVS Health from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 8th. Finally, Morgan Stanley upped their price objective on CVS Health from $80.00 to $82.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $78.25.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.